Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Joseph Boyle, David C. Wheeler, Ryan Naum, Paula Burke Brockenbrough, Michelle Gebhardt, LaVon Smith, Tremetris Harrell, Danielle Stewart & Kelly Gwathmey. (2023) Analysis of the spatial distribution of amyotrophic lateral sclerosis in Virginia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 669-677.
Read now
Read now
Loreto Martinez-Gonzalez & Ana Martinez. (2023) Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 32:2, pages 141-160.
Read now
Read now
R. J. Nona, J. M. Greer, R. D. Henderson & P. A. McCombe. (2023) HLA and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 24-32.
Read now
Read now
G David Batty & Catharine R Gale. (2021) Pre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study. Clinical Epidemiology 13, pages 941-947.
Read now
Read now
Dongqing Gu, Shan Ou, Mingshuang Tang, Zhiyong Yin, Zhengguo Wang & Guodong Liu. (2021) Trauma and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 170-185.
Read now
Read now
Yaira Hamama-Raz, Yair Norden & Eli Buchbinder. (2021) The double sides of hope: The meaning of hope among amyotrophic lateral sclerosis (ALS) patients. Death Studies 45:3, pages 238-247.
Read now
Read now
Hilmi Uysal, Parvin Taghiyeva, Mehtap Türkay, Fırat Köse & Mehmet Aktekin. (2021) Amyotrophic lateral sclerosis in Antalya, Turkey. A prospective study, 2016–2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 101-107.
Read now
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Read now
Orly Goldstein, Merav Kedmi, Mali Gana-Weisz, Beatrice Nefussy, Batel Vainer, Yaara Fainmesser, Vivian E. Drory & Avi Orr-Urtreger. (2020) A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 280-285.
Read now
Read now
Ruth M. Pfeiffer, Bernd Mayer, Ralph W. Kuncl, David P. Check, Elizabeth K. Cahoon, Donna R. Rivera & D. Michal Freedman. (2020) Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 235-245.
Read now
Read now
. (2019) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:sup1, pages 206-216.
Read now
Read now
Mohammad Hassan Baig, Abu Baker, Ghulam M Ashraf & Jae-June Dong. (2019) ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects. Expert Review of Proteomics 16:10, pages 857-870.
Read now
Read now
Pamela A. McCombe, Robert D. Henderson, Aven Lee, John D. Lee, Trent M. Woodruff, Restuadi Restuadi, Allan McRae, Naomi R. Wray, Shyuan Ngo & Frederik J. Steyn. (2019) Gut microbiota in ALS: possible role in pathogenesis?. Expert Review of Neurotherapeutics 19:9, pages 785-805.
Read now
Read now
Rituparna Bhattacharya, Raymond A. Harvey, Keli Abraham, Jon Rosen & Paul Mehta. (2019) Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 251-259.
Read now
Read now
Danielle Leighton, Judith Newton, Shuna Colville, Andrew Bethell, Gillian Craig, Laura Cunningham, Moira Flett, Dianne Fraser, Janice Hatrick, Helen Lennox, Laura Marshall, Dympna McAleer, Alison McEleney, Kitty Millar, Ann Silver, Laura Stephenson, Susan Stewart, Dorothy Storey, Gill Stott, Carol Thornton, Carolyn Webber, Harry Gordon, Giulia Melchiorre, Laura Sherlock, Emily Beswick, David Buchanan, Sharon Abrahams, Anthony Bateman, Jenny Preston, Callum Duncan, Richard Davenport, George Gorrie, Ian Morrison, Robert Swingler, Siddharthan Chandran & Suvankar Pal. (2019) Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 242-250.
Read now
Read now
Oliver Höffken, Alena Schmelz, Melanie Lenz, Kai Gruhn, Torsten Grehl, Martin Tegenthoff & Matthias Sczesny-Kaiser. (2019) Excitability in somatosensory cortex correlates with motoric impairment in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 192-198.
Read now
Read now
Michael Hinchcliffe & Alan Smith. (2017) Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degenerative Neurological and Neuromuscular Disease 7, pages 61-70.
Read now
Read now
Robert G. Miller & Stanley H. Appel. (2017) Introduction to supplement: the current status of treatment for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:sup1, pages 1-4.
Read now
Read now
Mamede De Carvalho, Adam Ryczkowski, Peter Andersen, Marta Gromicho, Julian Grosskreutz, Magdalena Kuźma-Kozakiewicz, Susanne Petri, Maria Piotrkiewicz & Gabriel Miltenberger Miltenyi. (2017) International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 505-510.
Read now
Read now
Marco Vinceti, Carlotta Malagoli, Sara Fabbi, Leeka Kheifets, Federica Violi, Maurizio Poli, Salvatore Caldara, Daniela Sesti, Silvia Violanti, Paolo Zanichelli, Barbara Notari, Roberto Fava, Alessia Arena, Roberta Calzolari, Tommaso Filippini, Laura Iacuzio, Elisa Arcolin, Jessica Mandrioli, Nicola Fini, Anna Odone, Carlo Signorelli, Francesco Patti, Mario Zappia, Vladimiro Pietrini, Paola Oleari, Sergio Teggi, Grazia Ghermandi, Angela Dimartino, Caterina Ledda, Cristina Mauceri, Salvatore Sciacca, Maria Fiore & Margherita Ferrante. (2017) Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 583-589.
Read now
Read now
Marina Tesauro, Michela Consonni, Tommaso Filippini, Letizia Mazzini, Fabrizio Pisano, Adriano Chiò, Aniello Esposito & Marco Vinceti. (2017) Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 284-290.
Read now
Read now
Gary G. Schwartz & Marilyn G. Klug. (2016) Motor neuron disease mortality rates in U.S. states are associated with well water use. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 528-534.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
Elena V. Lysogorskaia, Nataliya Yu Abramycheva, Mariya N. Zakharova, Mariya S. Stepanova, Anna A. Moroz, Alexey V. Rossokhin & Sergey N. Illarioshkin. (2016) Genetic studies of Russian patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 135-141.
Read now
Read now
Articles from other publishers (94)
Nils Skajaa, Emil Bjerregaard Riahi, Szimonetta Komjáthiné Szépligeti, Erzsébet Horváth‐Puhó, Trine Toft Sørensen, Victor W. Henderson & Henrik Toft Sørensen. (2023) Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population‐based cohort study. Brain and Behavior 13:6.
Crossref
Crossref
Qianqian Zhang, Qingyang Li, Huihui Zhao, Mingzhu Shu, Maotao Luo, Yanan Li, Yu Ding, Shiyu Shi, Xi Cheng & Qi Niu. (2023) Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study. Frontiers in Neurology 14.
Crossref
Crossref
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar & Shahid Bashir. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
147
169
.
Kateřina Klíčová & Jan Mareš. (2023) Molecular and cellular biology of amyotrophic lateral sclerosis. Neurologie pro praxi 24:1, pages 50-53.
Crossref
Crossref
Deepti Katiyar, Shipra Singhal, Priya Bansal, K. Nagarajan & Parul Grover. (2023) Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis. 3 Biotech 13:2.
Crossref
Crossref
Maruša Barbo & Metka Ravnik-Glavač. (2023) Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes 14:2, pages 325.
Crossref
Crossref
Anna Behler, Hans-Peter Müller, Albert C. Ludolph & Jan Kassubek. (2023) Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development. International Journal of Molecular Sciences 24:3, pages 1911.
Crossref
Crossref
Piotr Włodarczyk, Mikołaj Witczak, Agnieszka Gajewska, Tomasz Chady & Igor Piotrowski. (2022) The role of TDP-43 protein in amyotrophic lateral sclerosis. Journal of Medical Science 91:4, pages e710.
Crossref
Crossref
Seyed-Amirabbas Ahadiat & Zeinab Hosseinian. (2022) The Role of Biomaterials in Treating Lou Gehrig’s Disease. Archives of Neuroscience 9:4.
Crossref
Crossref
Duygu Aydemir, Selcuk Surucu, Ayse Nazli Basak & Nuriye Nuray Ulusu. (2022) Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis. Cells 11:22, pages 3569.
Crossref
Crossref
Pauline A. Gelon, Paul A. Dutchak & Chantelle F. Sephton. (2022) Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Cristiano Farace, Giovanni Fiorito, Andrea Pisano, Federica Etzi, Angela Sabalic, Grazia Fenu, Yolande Asara, Giuliana Solinas & Roberto Madeddu. (2022) Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case–control studies. Neurological Sciences 43:10, pages 5851-5859.
Crossref
Crossref
Balázs Sonkodi, Éva Pállinger, Tamás Radovits, Emese Csulak, Kinga Shenker-Horváth, Bence Kopper, Edit I. Buzás, Nóra Sydó & Béla Merkely. (2022) CD3+/CD56+ NKT-like Cells Show Imbalanced Control Immediately after Exercise in Delayed-Onset Muscle Soreness. International Journal of Molecular Sciences 23:19, pages 11117.
Crossref
Crossref
Sigal Ben-Zaken, Beatrice Nefussy, Yoav Meckel, Alon Eliakim, Dan Nemet, Marc Gotkine, Dana Lorber, Aviva Zeev & Vivian E. Drory. (2022) Common genetic basis of ALS patients and soccer players may contribute to disease risk. Neurological Sciences 43:7, pages 4231-4238.
Crossref
Crossref
Aracely A. Pérez Gómez, Moumita Karmakar, Raymond J. Carroll, Koedi S. Lawley, Katia Amstalden, Colin R. Young, David W. Threadgill, C. Jane Welsh & Candice Brinkmeyer-Langford. (2022) Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models. Cells 11:13, pages 2044.
Crossref
Crossref
Sarah Jacob, Ronak Kapadia, Tyler Soule, Honglin Luo, Kerri L. Schellenberg, Renée N. Douville & Gerald Pfeffer. (2022) Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections. Frontiers in Neurology 13.
Crossref
Crossref
Robert David Henderson, Kasper Planeta Kepp & Andrew Eisen. (2022) ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion. Frontiers in Neurology 13.
Crossref
Crossref
Johnson Olaleye Oladele, Adenike T. Oladiji, Oluwaseun Titilope Oladele & Oyedotun M. Oyeleke. 2022. Reactive Oxygen Species. Reactive Oxygen Species.
Vivek Pai, Chintan R Trivedi, Bhujang Pai & Saravana K Swaminathan. (2022) T1 hyperintensity in the spinal cord: A diagnostic marker of amyotrophic lateral sclerosis?. Journal of Clinical Imaging Science 12, pages 20.
Crossref
Crossref
John A. Edgar, Russell J. Molyneux & Steven M. Colegate. (2022) 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases. Chemical Research in Toxicology 35:3, pages 340-354.
Crossref
Crossref
Virginie Bottero, Jose A. Santiago, James P. Quinn & Judith A. Potashkin. (2022) Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Orietta Pansarasa, Maria Garofalo, Eveljn Scarian, Francesca Dragoni, Jessica Garau, Rosalinda Di Gerlando, Luca Diamanti, Matteo Bordoni & Stella Gagliardi. (2022) Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2580.
Crossref
Crossref
Thomas M. Petro, Irina V. Agarkova, Ahmed Esmael, David D. Dunigan, James L. Van Etten & Gary L. Pattee. (2022) Chlorovirus ATCV-1 Accelerates Motor Deterioration in SOD1-G93A Transgenic Mice and Its SOD1 Augments Induction of Inflammatory Factors From Murine Macrophages. Frontiers in Neurology 13.
Crossref
Crossref
Suvithanandhini Loganathan, Bryce A. Wilson, Sara B. Carey, Ernesto Manzo, Archi Joardar, Berrak Ugur & Daniela C. Zarnescu. (2022) TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS. Metabolites 12:2, pages 101.
Crossref
Crossref
Ahmed Salem, Carter J. Wilson, Benjamin S. Rutledge, Allison Dilliott, Sali Farhan, Wing-Yiu Choy & Martin L. Duennwald. (2022) Matrin3: Disorder and ALS Pathogenesis. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Oscar J. Wambuguh. 2022. Research Anthology on Pediatric and Adolescent Medicine. Research Anthology on Pediatric and Adolescent Medicine
135
177
.
Francesco Lotti & Serge Przedborski. 2022. Vertebrate Motoneurons. Vertebrate Motoneurons
323
352
.
Tobias MollJack N.G. MarshallNikita SoniSai ZhangJohnathan Cooper-KnockPamela J. Shaw. (2021) Membrane lipid raft homeostasis is directly linked to neurodegeneration. Essays in Biochemistry 65:7, pages 999-1011.
Crossref
Crossref
David Mantle, Robert A. Heaton & Iain P. Hargreaves. (2021) Coenzyme Q10, Ageing and the Nervous System: An Overview. Antioxidants 11:1, pages 2.
Crossref
Crossref
Salvatore D’Antona, Martina Caramenti, Danilo Porro, Isabella Castiglioni & Claudia Cava. (2021) Amyotrophic Lateral Sclerosis: A Diet Review. Foods 10:12, pages 3128.
Crossref
Crossref
Ingridy Barbalho, Ricardo Valentim, Mário Dourado Júnior, Daniele Barros, Hércules Pedrosa Júnior, Felipe Fernandes, César Teixeira, Thaísa Lima, Jailton Paiva & Danilo Nagem. (2021) National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases. BMC Neurology 21:1.
Crossref
Crossref
Aracely A. Perez Gomez, Moumita Karmakar, Raymond J. Carroll, Koedi S. Lawley, Katia Amstalden, Colin R. Young, David W. Threadgill, C. Jane Welsh & Candice Brinkmeyer-Langford. (2021) Genetic and immunological contributors to virus-induced paralysis. Brain, Behavior, & Immunity - Health 18, pages 100395.
Crossref
Crossref
Lassi Koski, Cecilia Ronnevi, Elina Berntsson, Sebastian K. T. S. Wärmländer & Per M. Roos. (2021) Metals in ALS TDP-43 Pathology. International Journal of Molecular Sciences 22:22, pages 12193.
Crossref
Crossref
Esteban Rodríguez-Arce & Marianela Saldías. (2021) Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases. Biomedicine & Pharmacotherapy 143, pages 112236.
Crossref
Crossref
Polina S. Goncharova, Tatiana K. Davydova, Tatiana E. Popova, Maxim A. Novitsky, Marina M. Petrova, Oksana A. Gavrilyuk, Mustafa Al-Zamil, Natalia G. Zhukova, Regina F. Nasyrova & Natalia A. Shnayder. (2021) Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis. Nutrients 13:11, pages 3804.
Crossref
Crossref
A. V. Savinova, N. A. Shnayder & R. F. Nasyrova. (2021) Genetics of familial amyotrophic lateral sclerosis. Bulletin of Siberian Medicine 20:3, pages 193-202.
Crossref
Crossref
Jannigje Rachel Kok, Nelma M. Palminha, Cleide Dos Santos Souza, Sherif F. El-Khamisy & Laura Ferraiuolo. (2021) DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cellular and Molecular Life Sciences 78:15, pages 5707-5729.
Crossref
Crossref
Yongzhi Xie, Ximei Luo, Haiqing He & Min Tang. (2021) Novel Insight Into the Role of Immune Dysregulation in Amyotrophic Lateral Sclerosis Based on Bioinformatic Analysis. Frontiers in Neuroscience 15.
Crossref
Crossref
Rosario Vasta, Fabrizio D’Ovidio, Giancarlo Logroscino & Adriano Chiò. (2021) The links between diabetes mellitus and amyotrophic lateral sclerosis. Neurological Sciences 42:4, pages 1377-1387.
Crossref
Crossref
Riccardo Oggiano, Andrea Pisano, Angela Sabalic, Cristiano Farace, Grazia Fenu, Simone Lintas, Giovanni Forte, Beatrice Bocca & Roberto Madeddu. (2020) An overview on amyotrophic lateral sclerosis and cadmium. Neurological Sciences 42:2, pages 531-537.
Crossref
Crossref
Chia-Hui Huang, Bak-Sau Yip, David Taniar, Chi-Shin Hwang & Tun-Wen Pai. (2021) Comorbidity Pattern Analysis for Predicting Amyotrophic Lateral Sclerosis. Applied Sciences 11:3, pages 1289.
Crossref
Crossref
Hasan Aykut Karaboga, Aslihan Gunel, Senay Vural Korkut, Ibrahim Demir & Resit Celik. (2021) Bayesian Network as a Decision Tool for Predicting ALS Disease. Brain Sciences 11:2, pages 150.
Crossref
Crossref
Angeline S. Andrew, Erik P. Pioro, Meifang Li, Xun Shi, Jiang Gui, Elijah W. Stommel, Tanya H. Butt, Daniel Peipert, Patricia Henegan, Maeve Tischbein, Pamela Cazzolli, John Novak, Adam Quick, K. Doug Pugar, Komal Sawlani, Bashar Katirji, Todd A. Hayes, D. Kevin Horton, Paul Mehta & Walter G. Bradley. (2021) The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry. Neuroepidemiology 55:3, pages 196-205.
Crossref
Crossref
Guodong Liu, Shan Ou, Huijie Cui, Xuan Li, Zhiyong Yin, Dongqing Gu & Zhengguo Wang. (2021) Head Injury and Amyotrophic Lateral Sclerosis: A Meta-Analysis. Neuroepidemiology 55:1, pages 11-19.
Crossref
Crossref
Pooja Shree Mishra, Hejer Boutej, Geneviève Soucy, Christine Bareil, Sunny Kumar, Vincent Picher-Martel, Nicolas Dupré, Jasna Kriz & Jean-Pierre Julien. (2020) Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Crossref
Raygene Martier & Pavlina Konstantinova. (2020) Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock. Frontiers in Neuroscience 14.
Crossref
Crossref
Hakan Cetin, Jiangwei Sun, Catarina Almqvist, Berthold Reichardt, Matthias Tomschik, Fritz Zimprich, Fang Fang & Caroline Ingre. (2020) No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study. Scientific Reports 10:1.
Crossref
Crossref
Ádám Mészáros, Kinga Molnár, Bernát Nógrádi, Zsófia Hernádi, Ádám Nyúl-Tóth, Imola Wilhelm & István A. Krizbai. (2020) Neurovascular Inflammaging in Health and Disease. Cells 9:7, pages 1614.
Crossref
Crossref
B. Kuraszkiewicz, H. Goszczyńska, T. Podsiadły-Marczykowska, M. Piotrkiewicz, P. Andersen, M. Gromicho, J. Grosskreutz, M. Kuźma-Kozakiewicz, S. Petri, B. Stubbendorf, K. Szacka, H. Uysal & M. de Carvalho. (2020) Potential Preventive Strategies for Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 14.
Crossref
Crossref
Raena Eldridge, Daniel Osorio, Katia Amstalden, Caitlin Edwards, Colin R. Young, James J. Cai, Kranti Konganti, Andrew Hillhouse, David W. Threadgill, C. Jane Welsh & Candice Brinkmeyer-Langford. (2020) Antecedent presentation of neurological phenotypes in the Collaborative Cross reveals four classes with complex sex-dependencies. Scientific Reports 10:1.
Crossref
Crossref
Krishna C. Aluri, Joseph P. Salisbury, Jochen H. M. Prehn & Jeffrey N. Agar. (2020) Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration. Scientific Reports 10:1.
Crossref
Crossref
Haley Yost, Riya Patel, Anders Kipp & Tanea T. Reed. 2005. Bailey's Industrial Oil and Fat Products. Bailey's Industrial Oil and Fat Products
1
29
.
Sandra Carrera-Juliá, Mari Luz Moreno, Carlos Barrios, Jose Enrique de la Rubia Ortí & Eraci Drehmer. (2020) Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Frontiers in Physiology 11.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Mariana Dutra Brito, Gustavo Ferro Gomes da Silva, Erick Mutti Tilieri, Beatriz Grisolia Araujo, Michele Longoni Calió & Tatiana Rosado Rosenstock. (2019) Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review. Frontiers in Neurology 10.
Crossref
Crossref
Trine Toft Sørensen, Erzsébet Horváth-Puhó, Mette Nørgaard, Vera Ehrenstein & Victor W Henderson. (2019) Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study. BMJ Open 9:7, pages e030015.
Crossref
Crossref
Grace Xia Chen, Andrea Martine ’t Mannetje, Jeroen Douwes, Leonard van den Berg, Neil Pearce, Hans Kromhout, Wendyl D’Souza, Melanie McConnell, Bill Glass, Naomi Brewer & David J McLean. (2019) Occupation and motor neuron disease: a New Zealand case–control study. Occupational and Environmental Medicine 76:5, pages 309-316.
Crossref
Crossref
Agnese Gugliandolo, Placido Bramanti & Emanuela Mazzon. (2019) Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?. Stem Cells International 2019, pages 1-16.
Crossref
Crossref
M Luisetto*N Almukhtar, AY Rafa, BN Ahmadabadi & GR Mashori. (2019) Role of plants, environmental toxins and physical neurotoxicological factors in Amyotrophic lateral sclerosis, Alzheimer Disease and other Neurodegenerative Diseases. Journal of Neuroscience and Neurological Disorders 3:1, pages 001-086.
Crossref
Crossref
Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum & Mustafa Y. Sir. (2019) Tollgate-based progression pathways of ALS patients. Journal of Neurology 266:3, pages 755-765.
Crossref
Crossref
Oscar J. Wambuguh. 2019. Examining the Causal Relationship Between Genes, Epigenetics, and Human Health. Examining the Causal Relationship Between Genes, Epigenetics, and Human Health
425
467
.
Abdeljalil Elgot, Hasna Lahouaoui, Ouassil El Kherchi & Nadia Zouhairi. 2019. Handbook of Research on Global Environmental Changes and Human Health. Handbook of Research on Global Environmental Changes and Human Health
286
304
.
Sonja Korner, Johanna Kammeyer, Antonia Zapf, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Bożenna Kuraszkiewicz, Hanna Goszczynska, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho & Susanne Petri. (2019) Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population. Aging and disease 10:2, pages 205.
Crossref
Crossref
Francesca De Giorgio, Cheryl Maduro, Elizabeth M. C. Fisher & Abraham Acevedo-Arozena. (2019) Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Disease Models & Mechanisms 12:1.
Crossref
Crossref
Vijay Kumar, Tara Kashav & Md. Imtaiyaz Hassan. 2019. Pathology, Prevention and Therapeutics of Neurodegenerative Disease. Pathology, Prevention and Therapeutics of Neurodegenerative Disease
207
224
.
Germán Sánchez-Díaz, Francisco Escobar, Hannah Badland, Greta Arias-Merino, Manuel Posada de la Paz & Verónica Alonso-Ferreira. (2018) Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain. International Journal of Environmental Research and Public Health 15:11, pages 2522.
Crossref
Crossref
Nishad Khamankar, Grant Coan, Barry Weaver & Cassie S. Mitchell. (2018) Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols. Frontiers in Neurology 9.
Crossref
Crossref
Arianna Novati, Thomas Hentrich, Zinah Wassouf, Jonasz J. Weber, Libo Yu-Taeger, Nicole Déglon, Huu Phuc Nguyen & Julia M. Schulze-Hentrich. (2018) Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease. Scientific Reports 8:1.
Crossref
Crossref
Bozenna Kuraszkiewicz, Teresa Podsiadły-Marczykowska, Hanna Goszczyńska & Maria Piotrkiewicz. (2018) Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?. Frontiers in Neurology 9.
Crossref
Crossref
S. Bräuer, V. Zimyanin & A. Hermann. (2018) Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. Journal of Neural Transmission 125:4, pages 591-613.
Crossref
Crossref
Leonie Ebel, Susanne Petri, Joachim K. Krauss, Reinhard Dengler & Martina de Zwaan. (2018) Lack of an association between attention-deficit/hyperactivity disorder (ADHD) and amyotrophic lateral sclerosis (ALS). Journal of the Neurological Sciences 385, pages 7-11.
Crossref
Crossref
Jie Zhang, Huiting Liang, Lei Zhu, Weiming Gan, Chunyan Tang, Jiao Li & Renshi Xu. (2017) Expression and Distribution of Arylsulfatase B are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice. Molecular Neurobiology 55:2, pages 1323-1337.
Crossref
Crossref
Mònica Povedano, Marc Saez, Juan-Antonio Martínez-Matos & Maria Antònia Barceló. (2018) Spatial Assessment of the Association between Long-Term Exposure to Environmental Factors and the Occurrence of Amyotrophic Lateral Sclerosis in Catalonia, Spain: A Population-Based Nested Case-Control Study. Neuroepidemiology 51:1-2, pages 33-49.
Crossref
Crossref
Chiara Monti, Ilaria Colugnat, Leonardo Lopiano, Adriano Chiò & Tiziana Alberio. (2016) Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease. Molecular Neurobiology 55:1, pages 370-381.
Crossref
Crossref
Sebastian Peters, Eva Zitzelsperger, Sabrina Kuespert, Sabine Iberl, Rosmarie Heydn, Siw Johannesen, Susanne Petri, Ludwig Aigner, Dietmar R. Thal, Andreas Hermann, Jochen H. Weishaupt, Tim-Henrik Bruun & Ulrich Bogdahn. (2017) The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis. Frontiers in Neurology 8.
Crossref
Crossref
Wenting Guo, Laura Fumagalli, Robert Prior & Ludo Van Den Bosch. (2017) Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells. Frontiers in Neuroscience 11.
Crossref
Crossref
Cecilia Wallin, Sabrina B. Sholts, Nicklas Österlund, Jinghui Luo, Jüri Jarvet, Per M. Roos, Leopold Ilag, Astrid Gräslund & Sebastian K. T. S. Wärmländer. (2017) Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation. Scientific Reports 7:1.
Crossref
Crossref
Jasna Lojk, Sonja Prpar Mihevc, Vladimir Boštjan Bregar, Mojca Pavlin & Boris Rogelj. (2017) The Effect of Different Types of Nanoparticles on FUS and TDP-43 Solubility and Subcellular Localization. Neurotoxicity Research 32:3, pages 325-339.
Crossref
Crossref
Candice L. Brinkmeyer-Langford, Raquel Rech, Katia Amstalden, Kelli J. Kochan, Andrew E. Hillhouse, Colin Young, C. Jane Welsh & David W. Threadgill. (2017) Host genetic background influences diverse neurological responses to viral infection in mice. Scientific Reports 7:1.
Crossref
Crossref
John D. Beard, Andrea L. Steege, Jun Ju, John Lu, Sara E. Luckhaupt & Mary K. Schubauer-Berigan. (2017) Mortality from Amyotrophic Lateral Sclerosis and Parkinson’s Disease Among Different Occupation Groups — United States, 1985–2011. MMWR. Morbidity and Mortality Weekly Report 66:27, pages 718-722.
Crossref
Crossref
Roberta Bonafede & Raffaella Mariotti. (2017) ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Tameko Kihira, Kazushi Okamoto, Iori Sakurai, Yuya Arakawa, Ikuro Wakayama, Koichi Takamiya, Ryo Okumura, Yuhto Iinuma, Keiko Iwai, Yasumasa Kokubo & Sohei Yoshida. (2017) Lifestyle Changes and Oxidative Stress in a High-incidence Area of Amyotrophic Lateral Sclerosis in the Southwestern Kii Peninsula, Japan. Internal Medicine 56:12, pages 1497-1506.
Crossref
Crossref
Margherita Lo Bello, Francesca Di Fini, Antonietta Notaro, Rossella Spataro, Francesca L. Conforti & Vincenzo La Bella. (2017) ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic <b><i>FUS </i></b>P525L Mutation Carriers. Neurodegenerative Diseases 17:6, pages 292-303.
Crossref
Crossref
Jessica Mandrioli, Bernhard Michalke, Nikolay Solovyev, Peter Grill, Federica Violi, Christian Lunetta, Amelia Conte, Valeria Ada Sansone, Mario Sabatelli & Marco Vinceti. (2017) Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations. Neurodegenerative Diseases 17:4-5, pages 171-180.
Crossref
Crossref
Aimee N. Winter, Matthew C. Brenner, Noelle Punessen, Michael Snodgrass, Caleb Byars, Yingyot Arora & Daniel A. Linseman. (2017) Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid. Oxidative Medicine and Cellular Longevity 2017, pages 1-13.
Crossref
Crossref
Zewen Liu, Tingyang Zhou, Alexander C. Ziegler, Peter Dimitrion & Li Zuo. (2017) Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxidative Medicine and Cellular Longevity 2017, pages 1-11.
Crossref
Crossref
Ola Nakken, Jonas Christoffer Lindstrøm, Ole-Bjørn Tysnes & Trygve Holmøy. (2016) Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age–period–cohort study. Journal of Neurology 263:12, pages 2378-2385.
Crossref
Crossref
Nilo Riva, Federica Agosta, Christian Lunetta, Massimo Filippi & Angelo Quattrini. (2016) Recent advances in amyotrophic lateral sclerosis. Journal of Neurology 263:6, pages 1241-1254.
Crossref
Crossref
Angelique Pasquinelli, Lucia Chico, Livia Pasquali, Costanza Bisordi, Annalisa Lo Gerfo, Monica Fabbrini, Lucia Petrozzi, Letizia Marconi, Elena Caldarazzo Ienco, Michelangelo Mancuso & Gabriele Siciliano. (2016) Gly482Ser PGC-1α Gene Polymorphism and Exercise-Related Oxidative Stress in Amyotrophic Lateral Sclerosis Patients. Frontiers in Cellular Neuroscience 10.
Crossref
Crossref
Steven A. Frank. (2016) Puzzles in modern biology. IV. Neurodegeneration, localized origin and widespread decay. F1000Research 5, pages 2537.
Crossref
Crossref
Javier Riancho, Pablo Lozano-Cuesta, Ana Santurtún, Pascual Sánchez-Juan, José Manuel López-Vega, José Berciano & José Miguel Polo. (2016) Amyotrophic Lateral Sclerosis in Northern Spain 40 Years Later: What Has Changed?. Neurodegenerative Diseases 16:5-6, pages 337-341.
Crossref
Crossref
Anjoscha Kaus & Dhruv Sareen. (2015) ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad. Frontiers in Cellular Neuroscience 9.
Crossref
Crossref
Stephanie Wallner, Sebastian Peters, Claudia Pitzer, Herbert Resch, Ulrich Bogdahn & Armin Schneider. (2015) The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity. Frontiers in Cell and Developmental Biology 3.
Crossref
Crossref